Shell Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80K Sell
5,398
-580
-10% -$8.6K ﹤0.01% 1052
2025
Q1
$107K Sell
5,978
-69
-1% -$1.24K 0.01% 998
2024
Q4
$105K Sell
6,047
-301
-5% -$5.23K ﹤0.01% 1042
2024
Q3
$89K Buy
+6,348
New +$89K ﹤0.01% 1072
2024
Q1
$55K Sell
6,704
-452
-6% -$3.71K ﹤0.01% 1145
2023
Q4
$64K Sell
7,156
-2,151
-23% -$19.2K ﹤0.01% 1138
2023
Q3
$83K Sell
9,307
-147
-2% -$1.31K ﹤0.01% 1120
2023
Q2
$145K Sell
9,454
-54
-0.6% -$828 0.01% 1024
2023
Q1
$214K Sell
9,508
-33
-0.3% -$743 0.01% 905
2022
Q4
$201K Sell
9,541
-1,936
-17% -$40.8K 0.01% 946
2022
Q3
$283K Sell
11,477
-3,008
-21% -$74.2K 0.01% 855
2022
Q2
$351K Buy
14,485
+24
+0.2% +$582 0.01% 901
2022
Q1
$373K Sell
14,461
-2,140
-13% -$55.2K 0.01% 952
2021
Q4
$515K Buy
16,601
+74
+0.4% +$2.3K 0.01% 887
2021
Q3
$401K Sell
16,527
-710
-4% -$17.2K 0.01% 965
2021
Q2
$251K Buy
17,237
+930
+6% +$13.5K ﹤0.01% 1174
2021
Q1
$407K Buy
16,307
+9,426
+137% +$235K 0.01% 936
2020
Q4
$188K Hold
6,881
﹤0.01% 1131
2020
Q3
$127K Hold
6,881
﹤0.01% 1135
2020
Q2
$140K Sell
6,881
-71
-1% -$1.45K ﹤0.01% 1100
2020
Q1
$101K Sell
6,952
-105
-1% -$1.53K ﹤0.01% 1118
2019
Q4
$100K Sell
7,057
-149
-2% -$2.11K ﹤0.01% 1184
2019
Q3
$84K Sell
7,206
-62
-0.9% -$723 ﹤0.01% 1202
2019
Q2
$146K Sell
7,268
-165
-2% -$3.32K ﹤0.01% 1147
2019
Q1
$168K Hold
7,433
﹤0.01% 1124
2018
Q4
$168K Sell
7,433
-600
-7% -$13.6K ﹤0.01% 1059
2018
Q3
$231K Buy
+8,033
New +$231K ﹤0.01% 1093